Chemotranscriptomic Profiling Defines Drug-Specific Signatures of the Glycopeptide Antibiotics Dalbavancin, Vancomycin and Chlorobiphenyl-Vancomycin in a VanB-Type-Resistant Streptomycete
Dalbavancin, vancomycin and chlorobiphenyl-vancomycin share a high degree of structural similarity and the same primary mode of drug action. All inhibit bacterial cell wall biosynthesis through complexation with intermediates in peptidoglycan biosynthesis mediated via interaction with peptidyl-d-ala...
Main Authors: | Andy Hesketh, Giselda Bucca, Colin P. Smith, Hee-Jeon Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-02-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2021.641756/full |
Similar Items
-
A Silkworm Infection Model for<i> </i>In Vivo<i> </i>Study<i> </i>of Glycopeptide Antibiotics
by: Aurora Montali, et al.
Published: (2020-06-01) -
Glycopeptide Hypersensitivity and Adverse Reactions
by: Vanthida Huang, et al.
Published: (2020-04-01) -
Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule
by: I. Yu. Torshin, et al.
Published: (2020-08-01) -
Vancomycin-resistant Enterococci: Epidemiology and Control
by: Yeşim ÇETİNKAYA
Published: (2000-03-01) -
In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
by: Dana Binyamin, et al.
Published: (2018-06-01)